Switch to:
More From Other Websites
2:37 pm Opko Health announced that the US FDA has accepted for review, the company's NDA for... Jul 28 2015
FDA Accepts OPKO's New Drug Application for Rayaldee™ Jul 28 2015
FDA Accepts OPKO’s New Drug Application for Rayaldee™ Jul 28 2015
Opko Health: Why Recent Weakness Represents A Golden Buying Opportunity Jul 24 2015
OPKO's Prostate Cancer Hit Jul 23 2015
OPKO Investee SciVac Announces the Completion of Transaction with Levon Resources Jul 10 2015
OPKO Announces Completion of Enrollment in Phase 3 Trial of hGH-CTP in Growth Hormone Deficient... Jul 10 2015
OPKO Announces Completion of Enrollment in Phase 3 Trial of hGH-CTP in Growth Hormone Deficient... Jul 10 2015
OPKO Investee SciVac Announces the Completion of Transaction with Levon Resources Jul 10 2015
FuelCell Energy, Windstream And Others Insiders Have Been Buying Jul 07 2015
4 Stocks Rising on Unusual Volume Jul 07 2015
OPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned... Jul 05 2015
OPKO HEALTH, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements... Jul 02 2015
OPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned... Jul 02 2015
OPKO and Bio-Reference Laboratories Announce Early Termination of the Waiting Period for Planned... Jul 02 2015
3 Reasons Why Opko Health's Stock Could Soar Jul 01 2015
MabVax Receives Coverage with a $5 Near-Term Price Target Based on Upcoming Catalysts Jul 01 2015
Conversion Right Extended on OPKO 3.0% Convertible Senior Notes Jul 01 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK